|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/42 | |
| A61K 39/395 | |||
| A61P 37/08 | |||
| A61K 39/00 |
| (11) | Number of the document | 2703415 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13185738.5 |
| Date of filing the European patent application | 2009-09-17 | |
| (97) | Date of publication of the European application | 2014-03-05 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 97819 P | 2008-09-17 | US |
| (72) |
Desjarlais, John R., US
Chu, Seung Y., US
Horton, Holly M., US
|
| (73) |
Xencor, Inc.,
111 W. Lemon Avenue, Monrovia, CA 91016,
US
|
| (54) | Compositions and methods for treating IgE-mediated disorders |
| Compositions and methods for treating IgE-mediated disorders |